Searched for
MYLAN INC.
Mylan Inc and Strides Shasun settle Agila payments rowThe deal was structured in a way that two escrows of $100 m each were provided for potential claims under the SPV in relation to regulatory...- Natco Pharma's partner MylanInc gets USFDA nod for cancer drugThe company's marketing partner Mylan Inc has received a tentative approval from the United States Food and Drug Administration (USFDA).
- Natco Pharma's US partner Mylan files application with USFDANatco Pharma's marketing partner Mylan Inc has filed an application with the US health regulator for generic Sorafenib tablets used mainly ...
- Mylan Inc to acquire Famy Care's certain business for $ 800 millionMumbai-based Famy Care is focused on female reproductive health care and is world leader in supplying a wide range of contraceptive pills.
- Natco Pharma's partner Mylan Inc files ANDA for generic CopaxoneAccording to IMS health, Copaxone 40 mg/mL had US sales of nearly USD 411.5 million for the 12 months ending June 30, 2014, it added.
- Agila Specialties recalls anaesthetic injection in USAgila Specialties, now a part of Mylan Inc, is recalling 10 lots of Etomidate injection, used in general anaesthesia in the US.
- Mylan launches breast cancer drug in IndiaDrug major Mylan Inc today said it has launched breast cancer drug Hertraz Herceptin in India.
- Strides completes $1.75 billion sale of Agila Specialties to MylanStrides Arcolab said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to $1.75 bill...
- Govt clears 15 FDI proposals worth Rs 2,000.5 croreThe Finance Ministry today said it has approved 15 foreign investment proposals totalling Rs 2,000.5 crore and recommended two FDI applicat...
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...
- Strides Arcolab surges over 7 pc as FIPB clears Mylan's FDI proposalSince Mylan's investment proposal is of over Rs 1,200 crore, it will go to the Cabinet Committee on Economic Affairs for final approval.
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...
- Mylan Inc's over 5,000 crore FDI in pharma sector may get government nodMylan Inc's over Rs 5,000 crore foreign direct investment proposal and a host of others in the pharmaceutical sector could soon see green l...
- Lupin falls nearly 5% on Mylan drug launch, Credit Suisse downgradeCredit Suisse downgraded Lupin from ‘outperform’ to ‘neutral’ rating and upped the price target from Rs 710 earlier to Rs 755.
- Settlement of Somaxon Pharmaceuticals patent suit in US soon: ZydusAhmedabad-based Zydus Cadila says, it agreed to settle a patent litigation suit with US-based Somaxon Pharmaceuticals for insomnia drug – S...
- Dr Reddy's Laboratories, Mylan launch Clopidogrel tablets in US marketDr Reddy's Laboratories announced today that it has launched Clopidogrel tablets, USP, a bioequivalent generic version of Plavix in the US ...
- US court rejects Mylan plea against RanbaxyA US court has dismissed Mylan’s attempt to prevent Ranbaxy from launching a low-cost version of Lipitor in Nov, expected to bring $550-600...
- USFDA nod likely for Ranbaxy generic drugThe US drug regulator has opposed American firm Mylan Inc's request to strip Ranbaxy Laboratories of its six-month exclusive rights to sell...
- Matrix Labs hits upper circuit on delisting plansShares of Matrix Laboratories were in the limelight after its parent Mylan Inc said it plans to acquire the remaining 29 per cent in the In...
- Natco inks agreement with Mylan for CopaxoneHome grown major Natco Pharma today said it has signed a licence and supply agreement with US-based Mylan for the global sale of generic ve...
Load More
